Kendra A. Ireland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kendra A. Ireland has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Katherine M. Davis
Emory University
8 shared publications - Mohammad R. Seyedsayamdost
Department of Chemistry, Princeton University, Princeton, USA
7 shared publications - Chase M. Kayrouz
Department of Chemistry, Princeton University, Princeton, USA
3 shared publications - Chase Kayrouz
Princeton University
2 shared publications Jonathan Huang
Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
2 shared publications- Marissa L. Abbott
Princeton University
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (40) , 42939-42948
Widespread Biosynthesis of Thiohistidine Dipeptides in Bacteria
Natural products have been paramount in inspiring novel chemistry as well as providing therapeutic agents and chemical tools for biological applications. A recently emerging class of natural products, the thio/seleno-imidazoles (TSIs), contains C–S or C–Se bonds that are installed by nonheme iron sulfoxide and selenoxide synthases (NHISSs). These TSIs, which include ergothioneine, are ubiquitous, but little is known about the broader TSI chemical space or co-occurrence with other biosynthetic enzymes. Here, we use NHISSs as a bioinformatic hook to identify a widespread family of biosynthetic gene clusters that encode a combination of NHISS and ATP-grasp enzymes. This search strategy enabled the discovery of two 2-thiohistidine-containing dipeptide natural products, one of which we isolated from the original microbial host. Structural and biochemical analyses of the corresponding biosynthetic enzymes revealed a novel NHISS active site architecture and an ATP-grasp enzyme with unprecedented substrate selectivity for 2-thiohistidine. Together, these results expand the known enzymology and distribution of TSIs and establish 2-thiohistidine as a biosynthetically encoded building block, enabling future discovery and functional investigation into this new natural product family.
- 1 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (40) , 42939-42948
Open AccessWidespread Biosynthesis of Thiohistidine Dipeptides in Bacteria
Natural products have been paramount in inspiring novel chemistry as well as providing therapeutic agents and chemical tools for biological applications. A recently emerging class of natural products, the thio/seleno-imidazoles (TSIs), contains C–S or C–Se bonds that are installed by nonheme iron sulfoxide and selenoxide synthases (NHISSs). These TSIs, which include ergothioneine, are ubiquitous, but little is known about the broader TSI chemical space or co-occurrence with other biosynthetic enzymes. Here, we use NHISSs as a bioinformatic hook to identify a widespread family of biosynthetic gene clusters that encode a combination of NHISS and ATP-grasp enzymes. This search strategy enabled the discovery of two 2-thiohistidine-containing dipeptide natural products, one of which we isolated from the original microbial host. Structural and biochemical analyses of the corresponding biosynthetic enzymes revealed a novel NHISS active site architecture and an ATP-grasp enzyme with unprecedented substrate selectivity for 2-thiohistidine. Together, these results expand the known enzymology and distribution of TSIs and establish 2-thiohistidine as a biosynthetically encoded building block, enabling future discovery and functional investigation into this new natural product family.
- Open Access
- 21 January 2025
- Published by Springer Nature in Nature Chemistry
- Vol. 17 (3) , 457
Author Correction: Discovery of the selenium-containing antioxidant ovoselenol derived from convergent evolution
- 21 January 2025
- Published by Springer Nature in Nature Chemistry
- Vol. 17 (3) , 457
Open AccessAuthor Correction: Discovery of the selenium-containing antioxidant ovoselenol derived from convergent evolution
- Open Access
- 8 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Structural and Functional Analysis of SAM-Dependent N-Methyltransferases Involved in Ovoselenol and Ovothiol Biosynthesis
Thio/selenoimidazole N-pi-methyltransferases are an emerging family of enzymes responsible for catalyzing the final enzymatic step in the biosynthesis of ovothiol and ovoselenol, S/Se-containing histidine-derived antioxidants. These unique enzymes are widespread among prokaryotes yet bear only marginal sequence similarity to other known methyltransferases. Likewise, little is known about the structural determinants of their reactivities. Here we report the first ligand-bound X-ray crystal structures of this family, including OvsM from the ovoselenol pathway as well as a member of a previously unknown clade of standalone ovothiol-biosynthetic N-pi-methyltransferases, which we have designated OvoM. Unlike previously reported ovothiol methyltransferases, which are fused as a C-terminal domain to the sulfoxide synthase OvoA, OvoMs are discrete enzymes and function independently. Comparative structural analyses of OvsM and OvoM reveal several conserved, ligand-induced tertiary and secondary structure changes, and suggest that similar conformational changes may apply to dual-domain OvoA enzymes. Mutagenesis experiments support a model in which the rearrangement of OvoA’s two domains facilitates substrate recognition through interaction with a key Tyr residue located within the domain linker. Furthermore, biochemical experiments highlight the essential role of an active site Asp residue, which likely functions as a catalytic base in the SN2-like nucleophilic substitution reaction catalyzed by these enzymes.
- 8 October 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessStructural and Functional Analysis of SAM-Dependent N-Methyltransferases Involved in Ovoselenol and Ovothiol Biosynthesis
Thio/selenoimidazole N-pi-methyltransferases are an emerging family of enzymes responsible for catalyzing the final enzymatic step in the biosynthesis of ovothiol and ovoselenol, S/Se-containing histidine-derived antioxidants. These unique enzymes are widespread among prokaryotes yet bear only marginal sequence similarity to other known methyltransferases. Likewise, little is known about the structural determinants of their reactivities. Here we report the first ligand-bound X-ray crystal structures of this family, including OvsM from the ovoselenol pathway as well as a member of a previously unknown clade of standalone ovothiol-biosynthetic N-pi-methyltransferases, which we have designated OvoM. Unlike previously reported ovothiol methyltransferases, which are fused as a C-terminal domain to the sulfoxide synthase OvoA, OvoMs are discrete enzymes and function independently. Comparative structural analyses of OvsM and OvoM reveal several conserved, ligand-induced tertiary and secondary structure changes, and suggest that similar conformational changes may apply to dual-domain OvoA enzymes. Mutagenesis experiments support a model in which the rearrangement of OvoA’s two domains facilitates substrate recognition through interaction with a key Tyr residue located within the domain linker. Furthermore, biochemical experiments highlight the essential role of an active site Asp residue, which likely functions as a catalytic base in the SN2-like nucleophilic substitution reaction catalyzed by these enzymes.
- 14 August 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (11) , 1868-1875
Discovery of the selenium-containing antioxidant ovoselenol derived from convergent evolution
Selenium is an essential micronutrient, but its presence in biology has been limited to protein and nucleic acid biopolymers. The recent identification of a biosynthetic pathway for selenium-containing small molecules suggests that there is a larger family of selenometabolites that remains to be discovered. Here we identify a recently evolved branch of abundant and uncharacterized metalloenzymes that we predict are involved in selenometabolite biosynthesis using a bioinformatic search strategy that relies on the mapping of composite active site motifs. Biochemical studies confirm this prediction and show that these enzymes form an unusual C–Se bond onto histidine, thus giving rise to a distinct selenometabolite and potent antioxidant that we have termed ovoselenol. Aside from providing insights into the evolution of this enzyme class and the structural basis of C–Se bond formation, our work offers a blueprint for charting the microbial selenometabolome in the future.
- 14 August 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (11) , 1868-1875
Discovery of the selenium-containing antioxidant ovoselenol derived from convergent evolution
Selenium is an essential micronutrient, but its presence in biology has been limited to protein and nucleic acid biopolymers. The recent identification of a biosynthetic pathway for selenium-containing small molecules suggests that there is a larger family of selenometabolites that remains to be discovered. Here we identify a recently evolved branch of abundant and uncharacterized metalloenzymes that we predict are involved in selenometabolite biosynthesis using a bioinformatic search strategy that relies on the mapping of composite active site motifs. Biochemical studies confirm this prediction and show that these enzymes form an unusual C–Se bond onto histidine, thus giving rise to a distinct selenometabolite and potent antioxidant that we have termed ovoselenol. Aside from providing insights into the evolution of this enzyme class and the structural basis of C–Se bond formation, our work offers a blueprint for charting the microbial selenometabolome in the future.
- Open Access
- 15 November 2023
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 62 (23) , 3337-3342
Structural Characterization and Ligand-Induced Conformational Changes of SenB, a Se-Glycosyltransferase Involved in Selenoneine Biosynthesis
Selenium (Se) is an essential micronutrient that is found naturally in proteins, nucleic acids, and natural products. Unlike selenoproteins and selenonucleic acids, little is known about the structures of biosynthetic enzymes that incorporate Se into small molecules. Here, we report the X-ray crystal structure of SenB, the first known Se-glycosyltransferase that was recently found to be involved in the biosynthesis of the Se-containing metabolite selenoneine. SenB catalyzes C-Se bond formation using selenophosphate and an activated uridine diphosphate sugar as a Se and glycosyl donor, respectively, making it the first known selenosugar synthase and one of only four bona fide C-Se bond-forming enzymes discovered to date. Our crystal structure, determined to 2.25 Å resolution, reveals that SenB is a type B glycosyltransferase, displaying the prototypical fold with two globular Rossmann-like domains and a catalytic interdomain cleft. By employing complementary structural biology techniques, we find that SenB undergoes both local and global substrate-induced conformational changes, demonstrating a significant increase in α-helicity and a transition to a more compact conformation. Our results provide the first structure of SenB and set the stage for further biochemical characterization in the future.
- 15 November 2023
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 62 (23) , 3337-3342
Open AccessStructural Characterization and Ligand-Induced Conformational Changes of SenB, a Se-Glycosyltransferase Involved in Selenoneine Biosynthesis
Selenium (Se) is an essential micronutrient that is found naturally in proteins, nucleic acids, and natural products. Unlike selenoproteins and selenonucleic acids, little is known about the structures of biosynthetic enzymes that incorporate Se into small molecules. Here, we report the X-ray crystal structure of SenB, the first known Se-glycosyltransferase that was recently found to be involved in the biosynthesis of the Se-containing metabolite selenoneine. SenB catalyzes C-Se bond formation using selenophosphate and an activated uridine diphosphate sugar as a Se and glycosyl donor, respectively, making it the first known selenosugar synthase and one of only four bona fide C-Se bond-forming enzymes discovered to date. Our crystal structure, determined to 2.25 Å resolution, reveals that SenB is a type B glycosyltransferase, displaying the prototypical fold with two globular Rossmann-like domains and a catalytic interdomain cleft. By employing complementary structural biology techniques, we find that SenB undergoes both local and global substrate-induced conformational changes, demonstrating a significant increase in α-helicity and a transition to a more compact conformation. Our results provide the first structure of SenB and set the stage for further biochemical characterization in the future.
- Open Access
- 28 August 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Structural Characterization and Ligand-Induced Conformational Changes of SenB, a Se-Glycosyltransferase Involved in Selenoneine Biosynthesis
Selenium (Se) is an essential micronutrient that is found naturally in proteins, nucleic acids, and natural products. Unlike selenoproteins and selenonucleic acids, little is known about the structures of the biosynthetic enzymes that incorporate Se into small molecules. Here, we report the X-ray crystal structure of SenB, the first known Se-glycosyltransferase that was recently found to be involved in the biosynthesis of the Se-containing metabolite selenoneine. SenB catalyzes C–Se bond formation using selenophosphate and an activated uridine diphosphate sugar as a Se and glycosyl donor, respectively, making it the first known selenosugar synthase and only one of four bona fide C–Se bond-forming enzymes discovered to date. Our crystal structure, determined to 2.25 Å resolution, reveals that SenB is a type B glycosyltransferase, displaying the prototypical fold with two globular Rossmann-like domains and a catalytic interdomain cleft. By employing complementary structural biology techniques, we find that SenB undergoes both local and global substrate-induced conformational changes, demonstrating a significant increase in α-helicity and a transition to a more compact conformation. Our results provide the first structure of SenB and set the stage for further biochemical characterization in the future.
- 28 August 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessStructural Characterization and Ligand-Induced Conformational Changes of SenB, a Se-Glycosyltransferase Involved in Selenoneine Biosynthesis
Selenium (Se) is an essential micronutrient that is found naturally in proteins, nucleic acids, and natural products. Unlike selenoproteins and selenonucleic acids, little is known about the structures of the biosynthetic enzymes that incorporate Se into small molecules. Here, we report the X-ray crystal structure of SenB, the first known Se-glycosyltransferase that was recently found to be involved in the biosynthesis of the Se-containing metabolite selenoneine. SenB catalyzes C–Se bond formation using selenophosphate and an activated uridine diphosphate sugar as a Se and glycosyl donor, respectively, making it the first known selenosugar synthase and only one of four bona fide C–Se bond-forming enzymes discovered to date. Our crystal structure, determined to 2.25 Å resolution, reveals that SenB is a type B glycosyltransferase, displaying the prototypical fold with two globular Rossmann-like domains and a catalytic interdomain cleft. By employing complementary structural biology techniques, we find that SenB undergoes both local and global substrate-induced conformational changes, demonstrating a significant increase in α-helicity and a transition to a more compact conformation. Our results provide the first structure of SenB and set the stage for further biochemical characterization in the future.
- 5 July 2023
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 18 (7) , 1473-1479
Robust Chemoenzymatic Synthesis of Keratinimicin Aglycone Analogues Facilitated by the Structure and Selectivity of OxyB
The emergence of multidrug-resistant pathogens poses a threat to public health and requires new antimicrobial agents. As the archetypal glycopeptide antibiotic (GPA) used against drug-resistant Gram-positive pathogens, vancomycin provides a promising starting point. Peripheral alterations to the vancomycin scaffold have enabled the development of new GPAs. However, modifying the core remains challenging due to the size and complexity of this compound family. The recent successful chemoenzymatic synthesis of vancomycin suggests that such an approach can be broadly applied. Herein, we describe the expansion of chemoenzymatic strategies to encompass type II GPAs bearing all aromatic amino acids through the production of the aglycone analogue of keratinimicin A, a GPA that is 5-fold more potent than vancomycin against Clostridioides difficile. In the course of these studies, we found that the cytochrome P450 enzyme OxyBker boasts both broad substrate tolerance and remarkable selectivity in the formation of the first aryl ether cross-link on the linear peptide precursors. The X-ray crystal structure of OxyBker, determined to 2.8 Å, points to structural features that may contribute to these properties. Our results set the stage for using OxyBker broadly as a biocatalyst toward the chemoenzymatic synthesis of diverse GPA analogues.
- 5 July 2023
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 18 (7) , 1473-1479
Robust Chemoenzymatic Synthesis of Keratinimicin Aglycone Analogues Facilitated by the Structure and Selectivity of OxyB
The emergence of multidrug-resistant pathogens poses a threat to public health and requires new antimicrobial agents. As the archetypal glycopeptide antibiotic (GPA) used against drug-resistant Gram-positive pathogens, vancomycin provides a promising starting point. Peripheral alterations to the vancomycin scaffold have enabled the development of new GPAs. However, modifying the core remains challenging due to the size and complexity of this compound family. The recent successful chemoenzymatic synthesis of vancomycin suggests that such an approach can be broadly applied. Herein, we describe the expansion of chemoenzymatic strategies to encompass type II GPAs bearing all aromatic amino acids through the production of the aglycone analogue of keratinimicin A, a GPA that is 5-fold more potent than vancomycin against Clostridioides difficile. In the course of these studies, we found that the cytochrome P450 enzyme OxyBker boasts both broad substrate tolerance and remarkable selectivity in the formation of the first aryl ether cross-link on the linear peptide precursors. The X-ray crystal structure of OxyBker, determined to 2.8 Å, points to structural features that may contribute to these properties. Our results set the stage for using OxyBker broadly as a biocatalyst toward the chemoenzymatic synthesis of diverse GPA analogues.
- 25 December 2022
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 14 (1) , 41-48
X-ray Emission Spectroscopy of Single Protein Crystals Yields Insights into Heme Enzyme Intermediates
Enzyme reactivity is often enhanced by changes in oxidation state, spin state, and metal-ligand covalency of associated metallocofactors. The development of spectroscopic methods for studying these processes coincidentally with structural rearrangements is essential for elucidating metalloenzyme mechanisms. Herein, we demonstrate the feasibility of collecting X-ray emission spectra of metalloenzyme crystals at a 3rd generation synchrotron source. In particular, we report the development of a von Hamos spectrometer for the collection of Fe Kβ emission optimized for analysis of dilute biological samples. We further showcase its application in crystals of the immunosuppressive heme-dependent enzyme indoleamine 2,3-dioxygenase. Spectra from protein crystals in different states were compared with relevant reference compounds. Complementary density functional calculations assessing covalency support our spectroscopic analysis and identify active site conformations that correlate to high- and low-spin states. These experiments validate the suitability of an X-ray emission approach for determining spin states of previously uncharacterized metalloenzyme reaction intermediates.
- 25 December 2022
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 14 (1) , 41-48
X-ray Emission Spectroscopy of Single Protein Crystals Yields Insights into Heme Enzyme Intermediates
Enzyme reactivity is often enhanced by changes in oxidation state, spin state, and metal-ligand covalency of associated metallocofactors. The development of spectroscopic methods for studying these processes coincidentally with structural rearrangements is essential for elucidating metalloenzyme mechanisms. Herein, we demonstrate the feasibility of collecting X-ray emission spectra of metalloenzyme crystals at a 3rd generation synchrotron source. In particular, we report the development of a von Hamos spectrometer for the collection of Fe Kβ emission optimized for analysis of dilute biological samples. We further showcase its application in crystals of the immunosuppressive heme-dependent enzyme indoleamine 2,3-dioxygenase. Spectra from protein crystals in different states were compared with relevant reference compounds. Complementary density functional calculations assessing covalency support our spectroscopic analysis and identify active site conformations that correlate to high- and low-spin states. These experiments validate the suitability of an X-ray emission approach for determining spin states of previously uncharacterized metalloenzyme reaction intermediates.